Senior Manager, Pharmacy Cancer Research Mayo Clinic
.75 pharmacology credits available
Learning Objectives:
Discuss the pharmacology and indications of the medications approved over the last 12 months for the management of patients with hematologic malignancies.
Review pivotal clinical trial data considered by the FDA when approving new oncologic agents and impact of these agents in advanced practice.
Identify the signs and symptoms of serious or life-threatening adverse effects of newly approved oncology medications.
